logo
Loading...
Multimodal assessment improves neuroprognosis performance in clinically unresponsive critical-care patients with brain injury

Medicine and Health

Multimodal assessment improves neuroprognosis performance in clinically unresponsive critical-care patients with brain injury

B. Rohaut, C. Calligaris, et al.

This study uncovers the complexities of predicting outcomes for unresponsive patients with acute brain injury. It highlights how a combination of behavioral, neuroimaging, and electrophysiological markers can improve prognostic accuracy, revealing that more assessment modalities lead to better outcomes. Conducted by a team of researchers including B. Rohaut, C. Calligaris, and others at the Paris Brain Institute, this research emphasizes the necessity of multimodal assessment in increasing neuroprognostic precision.... show more
Abstract
Accurately predicting functional outcomes for unresponsive patients with acute brain injury is a medical, scientific and ethical challenge. This prospective study assesses how a multimodal approach combining various numbers of behavioral, neuroimaging and electrophysiological markers affects the performance of outcome predictions. We analyzed data from 349 patients admitted to a tertiary neurointensive care unit between 2009 and 2021, categorizing prognoses as good, uncertain or poor, and compared these predictions with observed outcomes using the Glasgow Outcome Scale-Extended (GOS-E, levels ranging from 1 to 8, with higher levels indicating better outcomes). After excluding cases with life-sustaining therapy withdrawal to mitigate the self-fulfilling prophecy bias, our findings reveal that a good prognosis, compared with a poor or uncertain one, is associated with better one-year functional outcomes (common odds ratio (95% CI) for higher GOS-E: OR=14.57 (5.70-40.32), P<0.001; and 2.9 (1.56-5.45), P<0.001, respectively). Moreover, increasing the number of assessment modalities decreased uncertainty (OR = 0.35 (0.21-0.59), P<0.001) and improved prognostic accuracy (OR = 2.72 (1.18-6.47), P=0.011). Our results underscore the value of multimodal assessment in refining neuroprognostic precision, thereby offering a robust foundation for clinical decision-making processes for acutely brain-injured patients. ClinicalTrials.gov registration: NCT04534777.
Publisher
Nature Medicine
Published On
Aug 01, 2024
Authors
B. Rohaut, C. Calligaris, B. Hermann, P. Perez, F. Faugeras, F. Raimondo, J.-R. King, D. Engemann, C. Marois, L. Le Guennec, L. Di Meglio, A. Sangaré, M. O. Habert, V. Lambrecq, M. Valente, A. Ben Salah, A. Demertzi, L. Belloli, D. Manasova, L. Jodaitis, M. O. Munoz Musat, N. Pyatigorskaya, D. Galanaud, L. Puybasset, N. Weiss, S. Demeret, F. X. Lejeune, J. D. Sitt, L. Naccache
Tags
acute brain injury
functional outcomes
prognostic accuracy
multimodal assessment
neuroimaging
electrophysiological markers
unresponsive patients
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 22+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny